InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-10.6%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Bluestone Jeffrey, Director. Director active across 2 companies, notably Gilead Sciences, INC.. In total, 9 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €470k. History available since 5 May 2022. The latest transaction was disclosed on 20 January 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations9 total
5,000 shares@ US$67.4550.0% of flowCommon StockSEC:0001771814-26-000002
5,000 shares@ US$67.450.0002% mcap50.0% of flowCommon StockSEC:0001771814-26-000002:0
5,000 shares@ US$67.4517.2% of flowCommon StockSEC:0001127602-25-019182:0
5,000 shares@ US$109.7427.9% of flowCommon StockSEC:0001127602-25-019182:1
5,879 shares@ US$61.1720.5% of flowCommon StockSEC:0001127602-24-028213:0
2,444 shares0Common StockSEC:0001127602-22-013726:0
2,223 sharesCommon StockSEC:0001127602-22-013129:0
1,041 sharesCommon StockSEC:0001127602-21-030577:0
1,041 sharesCommon StockSEC:0001127602-21-030577
9 of 9 declarations
About Bluestone Jeffrey
Jeffrey Bluestone is a Director at Gilead Sciences, Inc. and Gilead Sciences Inc. He contributes to the governance of these companies, providing his expertise to guide strategic decisions. His role is essential for their development.
